Medicine

Gut health could play a role in how blood cancer patients respond to therapy

Marco Ruella of the Perelman School of Medicine says that researchers need to tackle the problems with CAR T cell therapy to increase survival rates and improve the quality of life for cancer survivors.

Person awake in bed with alarm clock reading 4 a.m.

Research shows how stress activates neurons that disrupt sleep

New research from Penn Medicine shows suppressing these neurons may be a promising target for therapies to treat stress-related sleep disorders, like insomnia and PTSD.

First in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses

The therapy tested in a Phase 1 clinical trial might drastically change the way the T cells work, potentially allowing the new CAR T cell product to work where other products have failed.

This Penn resident is behind an AI app aiming to reduce physician burnout

Penn Medicine resident Nikhil Illa is featured as the cofounder of Pocket Scribe, maker of a cloud-based app that assists physicians by using artificial intelligence to transcribe and sort dictated notes. The app won the Best Pitch Award at Pennovation’s annual accelerator pitch day.

A person leaving the hospital at the end of a long corridor.

One in six patients with opioid use disorder leaving the hospital before completing treatment

A new Penn Medicine analysis shows that discharges too early for patients with opioid use disorder increased over 50% between 2016 and 2020.

FDA approves two sickle cell therapies, including first CRISPR medicine

Kiran Musunuru of the Perelman School of Medicine says that gene editing will be the biggest story of the century.

Inclusive, ambitious research to meet the needs of a changing planet

Collaborative research communities supported by the Environmental Innovations Initiative are addressing issues related to climate action, stewardship of nature, and societal resilience.

A cancer vaccine, glowing tumors, lightning speed radiation: Three UPenn innovations to watch

Robert H. Vonderheide of the Perelman School of Medicine discusses three cancer treatment innovations that could be game changers for patients.

Most admired CEOs 2023: Kevin Mahoney, University of Pennsylvania Health System

Kevin Mahoney is lauded for his accomplishments as CEO of the University of Pennsylvania Health System.

Do biotin supplements actually do anything for hair loss?

Susan Taylor of the Perelman School of Medicine says that seeing a dermatologist for hair loss is a smarter strategy than taking biotin supplements.

Filters